Autor(es): Lima, Isabella ; Melo, Ailton de Souza ; Brandi, Ivar Viana ; Costa, Olívia Lúcia Nunes ; Santiago, Mittermayer Barreto ; Lima, Isabella ; Melo, Ailton de Souza ; Brandi, Ivar Viana ; Costa, Olívia Lúcia Nunes ; Santiago, Mittermayer Barreto
Data: 2014
Origem: Oasisbr
Assunto(s): Multiple sclerosis; Lupus; Lupoid sclerosis; Antiphospholipid syndrome
Texto completo: acesso restrito. p. 85-86
Submitted by Suelen Reis (suziy.ellen@gmail.com) on 2014-01-31T13:16:05Z No. of bitstreams: 1 00124743-200704000-00009.pdf: 97666 bytes, checksum: 36f1f3216456785daaf6fb596657b1e3 (MD5)
Approved for entry into archive by Rodrigo Meirelles (rodrigomei@ufba.br) on 2014-09-09T15:57:47Z (GMT) No. of bitstreams: 1 00124743-200704000-00009.pdf: 97666 bytes, checksum: 36f1f3216456785daaf6fb596657b1e3 (MD5)
Made available in DSpace on 2014-09-09T15:57:47Z (GMT). No. of bitstreams: 1 00124743-200704000-00009.pdf: 97666 bytes, checksum: 36f1f3216456785daaf6fb596657b1e3 (MD5) Previous issue date: 2007
A multiple sclerosis-like syndrome, also called lupoid sclerosis for having some lupus characteristics, has been described in a few reports. Recently, antiphospholipid antibodies have been demonstrated in patients with this syndrome, suggesting that they can participate in the etiopathogenic process, which can have therapeutic implications. We report the case of a patient previously diagnosed with multiple sclerosis who later presented with ANA positivity and antiphospholipid antibodies, livedo reticularis, and deep venous thrombosis, leading her to be characterized as having lupoid sclerosis. The patient was anticoagulated. Antiphospholipid antibodies may be involved in the pathogenesis of lupoid sclerosis.
